Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
29
Number of overlapping holdings
32.6%
% of WDNA's 91 holdings also in GNOM
70.7%
% of GNOM's 41 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in GNOM |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 1.9% | 7.4% | 1.9% |
|
CRISPR THERAPEUTICS AG | 1.8% | 4.9% | 1.8% |
|
ULTRAGENYX PHARMACEUTICAL IN | 1.6% | 4.7% | 1.6% |
|
BEAM THERAPEUTICS, INC. | 1.4% | 3.2% | 1.4% |
|
VERTEX PHARMACEUTICALS INC | 1.3% | 1.7% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to GNOM
|
IOVANCE BIOTHERAPEUTICS INC | 3.9% |
|
TWIST BIOSCIENCE CORP. | 3.4% |
|
FATE THERAPEUTICS INC | 3.1% |
 |
NOVOZYMES A/S-B SHARES | 2.4% |
|
BLUEPRINT MEDICINES CORP. | 2.2% |
|
BRIDGEBIO PHARMA, INC. | 2.0% |
|
ELI LILLY & CO | 1.9% |
 |
ALCOBRA LTD | 1.7% |
|
VERICEL CORPORATION | 1.7% |
|
AGIOS PHARMACEUTICALS INC | 1.6% |
WDNA Underweight Relative to GNOM
 |
ENI SPA-SPONSORED ADR | -7.2% |
|
NATERA INC | -5.5% |
|
MODERNA, INC. | -3.5% |
|
AGILENT TECHNOLOGIES INC | -3.2% |
|
ROCKET PHARMACEUTICALS, INC. | -3.2% |
|
CRISPR THERAPEUTICS AG | -3.2% |
|
ULTRAGENYX PHARMACEUTICAL IN | -3.2% |
|
AVIDITY BIOSCIENCES INC | -3.0% |
|
ILLUMINA INC | -2.8% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -2.6% |